SEC Form 4 · accession 0001104659-26-086328
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tracy Basso
Officer — EVP & CHRO
Period of report
Jul 21, 2026
Accepted (ET)
Jul 23, 2026 · 5:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jul 21, 2026 | F | 763 | — | D | 1,542 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of restricted stock units ("RSUs"), which vested on April 23, 2026, is based on a percentage and did not take into account any market value as the Issuer's ordinary shares are not listed or quoted on a recognized trading market.